Követés
Zoltán Hernádi
Zoltán Hernádi
University of Debrecen Medical and Health Science Center Department of Gynecologic Oncology
E-mail megerősítve itt: med.unideb.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Elevated human epididymis protein 4 concentrations in chronic kidney disease
B Nagy Jr, ZT Krasznai, H Balla, M Csobán, P Antal-Szalmás, Z Hernádi, ...
Annals of clinical biochemistry 49 (4), 377-380, 2012
1492012
Survivin promoter polymorphism and cervical carcinogenesis
AA Borbély, M Murvai, K Szarka, J Kónya, L Gergely, Z Hernádi, G Veress
Journal of clinical pathology 60 (3), 303-306, 2007
1002007
Role of the Na+/Ca2+ exchanger in calcium homeostasis and human sperm motility regulation
Z Krasznai, ZT Krasznai, M Morisawa, ZK Bazsáné, Z Hernádi, Z Fazekas, ...
Cell motility and the cytoskeleton 63 (2), 66-76, 2006
682006
Duration of HPV-associated risk for high-grade cervical intraepithelial neoplasia
Z Hernádi, L Gazdag, K Szőke, T Sápy, ZT Krasznai, J Kónya
European Journal of Obstetrics & Gynecology and Reproductive Biology 125 (1 …, 2006
552006
Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia
J Kónya, G Veress, A Juhász, K Szarka, T Sápy, Z Hernádi, L Gergely
Journal of clinical microbiology 38 (1), 408-411, 2000
452000
Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
K Szarka, G Veress, A Juhasz, J Konya, T Sapy, G Soos, Z Hernadi, ...
Anticancer research 20 (3B), 2161-2167, 2000
412000
Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias
J Kónya, G Veress, Z Hernádi, G Soós, J Czeglédy, L Gergely
Journal of medical virology 46 (1), 1-6, 1995
411995
Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions
Z Hernádi, K Szőke, T Sápy, ZT Krasznai, G Soós, G Veress, L Gergely, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 118 (2 …, 2005
402005
The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up
Z Hernádi, K Szarka, T Sápy, Z Krasznai, G Veress, R Póka
BJOG: an international journal of obstetrics and gynaecology 110 (2), 205-209, 2003
342003
Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer
Z Hernadi, B Juhasz, R Poka, LG Lampé
International Journal of Gynecology & Obstetrics 27 (2), 199-204, 1988
341988
Moderate variation of the oncogenic potential among high‐risk human papillomavirus types in gynecologic patients with cervical abnormalities
K Szőke, T Sápy, Z Krasznai, Z Hernádi, G Szládek, G Veress, J Dillner, ...
Journal of medical virology 71 (4), 585-592, 2003
312003
Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer
ZT Krasznai, E Friedländer, A Nagy, G Szabó, G Vereb, K Goda, ...
Anticancer research 25 (2A), 1187-1192, 2005
302005
Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG
ZT Krasznai, Á Tóth, P Mikecz, Z Fodor, G Szabó, L Galuska, Z Hernádi, ...
European Journal of Pharmaceutical Sciences 41 (5), 665-669, 2010
262010
Human papillomavirus type 18 E6* mRNA in primary tumors and pelvic lymph nodes of Hungarian patients with squamous cervical cancer
J Czeglédy, M Evander, Z Hernadi, L Gergely, G Wadell
International journal of cancer 56 (2), 182-186, 1994
261994
Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes
T Sápy, Z Hernádi, J Kónya, L Lukácskó
European Journal of Obstetrics & Gynecology and Reproductive Biology 90 (1 …, 2000
242000
Biphasic accumulation kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile in tumour cells and its modulation by lipophilic P-glycoprotein ligands
T Márián, L Balkay, G Szabó, ZT Krasznai, Z Hernádi, L Galuska, ...
European journal of pharmaceutical sciences 25 (2-3), 201-209, 2005
232005
Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review
K Kim, E Hernlund, Z Hernadi, J Révész, I Pete, A Szánthó, L Bodnar, ...
International Journal of Gynecologic Cancer 23 (5), 2013
222013
Phase II Clinical Evaluation of Etoposide (VP-16-213, Vepesid®) as a Second-Line Treatment in Ovarian Cancer: Results of the South-East European Oncology Group (SEEOG) Study
S Eckhardt, Z Hernádi, L Thurzó, A Telekes, B Sopkova, Z Mechl, ...
Oncology 47 (4), 289-295, 1990
221990
Sequence variation of human papillomavirus type 31 long control region: phylogenetic and functional implications
A Ferenczi, E Gyöngyösi, A Szalmas, Z Hernadi, Z Toth, J Konya, ...
Journal of medical virology 85 (5), 852-859, 2013
202013
Detection of human papillomavirus deoxyribonucleic acid in the female genital tract
J Czeglédy, L Gergely, Z Hernádi, R Poka
Medical microbiology and immunology 178, 309-314, 1989
201989
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20